CLINICAL_TRIALS
research
· 2024-11-08
Clinical Trial Update: StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms [Phase 1]
Summary
A Phase 1 clinical trial evaluating StrataMGT for reducing symptoms of Vulvar Lichen Sclerosus is currently recruiting. The study is sponsored by Andrew T. Gold…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Andrew T. Goldstein, MD | Conditions: Vulvar Lichen Sclerosus | Phase 1 | Status: RECRUITING